Temporal discontinuities in progression of NOD autoimmune diabetes

Immunologic Research

Volumn 16, Issue 2, 1997, Pages 137-147

  Rudy, George B ^a   Sutherland, Robyn M ^a   Lew, Andrew M ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Autoimmunity; Diabetes; NOD; Temporal

Indexed keywords

ARTICLE; AUTOIMMUNITY; DISEASE COURSE; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0030802075     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02786358     Document Type: Article

References (67)

1. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y: Breeding of a nonobese, diabetic strain of mice. Jikken Dobutsu Experimental Animals 1980;29:1-13.
2. Larger E, Becourt C, Bach JF, Boitard C: Pancreatic islet beta-cells drive T cell-immune responses in the nonobese diabetic mouse model. J Exp Med 1995;181:1635-1642.
3. Boitard C, Yasunami R, Dardenne M, Bach JF: T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J Exp Med 1989;169:1669-1680.
4. Bendelac A, Carnaud C, Boitard C, Bach JF: Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells. J Exp Med 1987; 166:823-832.
5. Ghosh S, Palmer SM, Rodrigues NR, Cordell HJ, Hearne CM, Cornall RJ, Prins JB, McShane P, Lathrop GM, Peterson LB, Wicker LS, Todd JA: Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nat Genet 1993;4:404-409.
6. Wicker LS, Miller BJ, Coker LZ, McNally SE, Scott S, Mullen Y, Appel MC: Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse. J Exp Med 1987;165:1639-1654.
7. Wicker LS, Todd JA, Peterson LB: Genetic control of autoimmune diabetes in the NOD mouse [review]. Annu Rev Immunol 1995;13:179-200.
8. Harrison L, Kay T: Transgenic and gene targeting strategies in insulin-dependent diabetes; in LeRoith D, Olefsky J, Taylor S (eds): Diabetes Mellitus: A Fundamental and Clinical Text. Philadelphia, Lippincott, 1996, pp 361-370.
9. Boitard C, Bendelac A, Richard MF, Carnaud C, Bach JF: Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells. Proc Natl Acad Sci USA 1988;85:9719-9723.
10. Harada M, Makino S: Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-Thy 1, 2 antibody. Jikken Dobutsu Experimental Animals 1986;35: 501-504.
11. Koike T, Itoh Y, Ishii T, Ito I, Takabayashi K, Maruyama N, Tomioka H, Yoshida S: Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice. Diabetes 1987;36:539-541.
12. Charlton B, Mandel TE: Progression from insulitis to beta-cell destruction in NOD mouse requires L3T4+ T-lymphocytes. Diabetes 1988;37:1108-1112.
13. Charlton B, Bacelj A, Mandel TE: Administration of silica particles or anti-Lyt2 antibody prevents beta-cell destruction in NOD mice given cyclophosphamide. Diabetes 1988;37:930-935.
14. Hutchings PR, Simpson E, O'Reilly LA, Lund T, Waldmann H, Cooke A: The involvement of Ly2+ T cells in beta cell destruction. J Autoimmun 1990;1:101-109.
15. Hayward AR, Shreiber M: Neonatal injection of CD3 antibody into nonobese diabetic mice reduces the incidence of insulitis and diabetes. J Immunol 1989;143:1555-1559.
16. Sempe P, Bedossa P, Richard MF, Villa MC, Bach JF, Boitard C: Anti-alpha/beta T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice. Eur J Immunol 1991;21:1163-1169.
17. Kelley VE, Gaulton GN, Hattori M, Ikegami H, Eisenbarth G, Strom TB: Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis. J Immunol 1988; 140:59-61.
18. Taki T, Nagata M, Ogawa W, Hatamori N, Hayakawa M, Hari J, Shii K, Baba S, Yokono K: Prevention of cyclophosphamide-induced and spontaneous diabetes in NOD/Shi/Kbe mice by anti-MHC class I Kd monoclonal antibody. Diabetes 1991;40: 1203-1209.
19. Andersson A, Forsgren S, Soderstrom A, Holmberg D: Monoclonal, natural antibodies prevent development of diabetes in the non-obese diabetic (NOD) mouse. J Autoimmunity 1991;4:733-4742.
20. Hurtenbach U, Lier E, Adorini L, Nagy ZA: Prevention of autoimmune diabetes in non-obese diabetic mice by treatment with a class II major histocompatibility complex-blocking peptide. J Exp Med 1993;177:1499-1504.
21. Katz J, Benoist C, Mathis D: Major histocompatibility complex class I molecules are required for the development of insulitis in nonobese diabetic mice. Eur J Immunol 1993;23:3358-3360.
22. Matsumoto M, Yagi H, Kunimoto K, Kawaguchi J, Makino S, Harada M: Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis. Cell Immunol 1993;148: 189-197.
23. Thivolet C, Bendelac A, Bedossa P, Bach JF, Carnaud C: CD8+ T cell homing to the pancreqas in the nonobese diabetic mouse is CD4+ T cell-dependent. J Immunol 1991; 146:85-88.
24. Wicker LS, Leiter EH, Todd JA, Renjilian RJ, Peterson E, Fischer PA, Podolin PL, Zijlstra M, Jaenisch R, Peterson LB: Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 1994;43:500-504.
25. Serreze DV, Leiter EH, Christianson GJ, Greiner D, Roopenian DC: Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes 1994;43: 505-509.
26. Sumida T, Furukawa M, Sakamoto A, Namekawa T, Maeda T, Zijlstra M, Iwamoto I, Koike T, Yoshida S, Tomioka H, Taniguchi M: Prevention of insulitis and diabetes in beta 2-microglobulin-deficient nonobese diabetic mice. Int Immunol 1994; 6:1445-1449.
27. Wang B, Gonzalez A, Benoist C, Mathis D: The role of cd8(+) t cells in the initiation of insulin-dependent diabetes mellitus. Eur J Immunol 1996;26:1762-1769.
28. Warram JH, Krolewski AS, Gottlieb MS, Kahn CR: Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med 1984;311:149-152.
29. Wicker LS, Miller BJ, Fischer PA, Pressey A, Peterson LB: Genetic control of diabetes and insulitis in the nonobese diabetic mouse. Pedigree analysis of a diabetic H-2nod/b heterozygote. J Immunol 1989;142:781-784.
30. Ogawa M, Maruyama T, Hasegawa T, Kanaya T, Kobayashi F, Tochino Y, Uda H: The inhibitory effect of neonatal thymectomy on the incidence of insulitis in non-obese diabetes (NOD) mice. Biomed Res 1985;6:103-105.
31. Ridge JP, Fuchs EJ, Matzinger P: Neonatal tolerance revisited: turning on newborn T cells with dendritic cells [see comments]. Science 1996;271:1723-1726.
32. Katz JD, Wang B, Haskins K, Benoist C, Mathis D: Following a diabetogenic T cell from genesis through pathogenesis. Cell 1993; 74:1089-1100.
33. Dardenne M, Lepault F, Bendelac A, Bach JF: Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning. Eur J Immunol 1989;19:889-895.
34. Hutchings PR, Cooke A: The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males. J Autoimmun 1990;3:175-185.
35. Gerling IC, Serreze DV, Christianson SW, Leiter EH: Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice. Diabetes 1992;41:1672-1676.
36. Tisch R, Yang XD, Singer SM, Liblau RS, Fugger L, McDevitt HO: Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice [see comments]. Nature 1993;366:72-75.
37. Bock T, Kjaer TW, Jorgensen M, Josefsen K, Rygaard J, Buschard K: Reduction of diabetes incidence in NOD mice by neonatal glucose treatment. Apmis 1991; 99:989-992.
38. Zhang ZJ, Davidson L, Eisenbarth G, Weiner HL: Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 1991;88:10,252-10,256.
39. Qin HY, Sadelain MW, Hitchon C, Lauzon J, Singh B: Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J Immunol 1993;150:2072-2080.
40. Fujita Y, Yui R, Kusumoto Y, Serizawa Y, Makino S, Tochino Y: Lymphocytic Insulitis in a 'nonobese diabetic (NOD)' strain of mice: an immunohistochemical and electron microscope investigation. Biomedical Research 1982; 3:429-443.
41. Fujino-Kurihara H, Fujita H, Hakura A, Nonaka K, Tarui S: Morphological aspects on pancreatic islets of non-obese diabetic (NOD) mice. Virchows Archiv B, Cell Pathol Mol Pathol 1985;49: 107-120.
42. Signore A, Cooke A, Pozzilli P, Butcher G, Simpson E, Beverley PC: Class-II and IL2 receptor positive cells in the pancreas of NOD mice. Diabetologia 1987;30:902-905.
43. Miyazaki A, Hanafusa T, Yamada K, Miyagawa J, Fujino-Kurihara H, Nakajima H, Nonaka K, Tarui S: Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: A longitudinal study. Clin Exp Immunol 1985;60:622-630.
44. Signore A, Pozzilli P, Gale EA, Andreani D, Beverley PC: The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice. Diabetologia 1989;32: 282-289.
45. Kanazawa Y, Komeda K, Sato S, Mori S, Akanuma K, Takaku F: Non-obese-diabetic mice: immune mechanisms of pancreatic beta-cell destruction. Diabetologia 1984; 27:113-115.
46. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS: The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 1986;29:267-274.
47. Pipeleers D, Ling Z: Pancreatic beta cells in insulin-dependent diabetes [review]. Diabetes Metab Rev 1992;8:209-227.
48. Sutherland DE, Sibley R, Xu XZ, Michael A, Srikanta AM, Taub F, Najarian J, Goetz FC: Twin-to-twin pancreas transplantation: reversal and reenactment of the pathogenesis of type I diabetes. Trans Assoc Am Physicians 1984; 97:80-87.
49. Itoh A, Maki T: Protection of nonobese diabetic mice from autoimmune diabetes by reduction of islet mass before insulitis. Proc Natl Acad Sci USA 1996;93: 11,053-11,056.
50. Bedossa P, Bendelac A, Bach JF, Carnaud C: Syngeneic T cell transfer of diabetes into NOD newborn mice: in situ studies of the autoimmune steps leading to insulin-producing cell destruction. Eur J Immunol 1989;19:1947-1951.
51. Hanninen A, Taylor C, Streeter PR, Stark LS, Sarte JM, Shizuru JA, Simell O, Michie SA: Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium. J Clin Invest 1993;92:2509-2515.
52. Yang XD, Michie SA, Tisch R, Karin N, Steinman L, McDevitt HO: Cell adhesion molecules: a selective therapeutic target for alleviation of IDDM. J Autoimmun 1994;7:859-864.
53. Faveeuw C, Gagnerault MC, Lepault F: Modifications of the expression of homing and adhesion molecules in infiltrated islets of Langerhans in NOD mice. Adv Exp Med Biol 1994;355:137-142.
54. Hanninen A, Salmi M, Simell O, Andrew D, Jalkanen S: Recirculation and homing of lymphocyte subsets - dual homing specificity of beta-7-integrin(high)-lymphocytes in nonobese diabetic mice. Blood 1996;88:934-944.
55. Hanninen A, Salmi M, Simell O, Jalkanen S: Mucosa-associated (beta-7-integrin(high)) lymphocytes accumulate early in the pancreas of nod mice and show aberrant recirculation behavior. Diabetes 1996;45:1173-1180.
56. Eisenbarth GS: Type I diabetes mellitus. A chronic autoimmune disease [review]. N Engl J Med 1986;314:1360-1368.
57. Dotta F, Eisenbarth GS: Type I diabetes mellitus: a predictable autoimmune disease with inter-individual variation in the rate of beta cell destruction [review]. Clin Immunol Immunopathol 1989;50: S85-95.
58. Signore A, Procaccini E, Toscano AM, Ferretti E, Williams AJ, Beales PE, Cugini P, Pozzilli P: Histological study of pancreatic beta-cell loss in relation to the insulitis process in the non-obese diabetic mouse. Histochemistry 1994;101: 263-269.
59. Atkinson MA, Maclaren NK: Autoantibodies in nonobese diabetic mice immunoprecipitate 64,000-Mr islet antigen. Diabetes 1988; 37:1587-1590 [published erratum appears in Diabetes 1989 May; 38(5):inside front cover].
60. Reddy S, Bibby N, Elliott RB: Longitudinal study of islet cell antibodies and insulin autoantibodies and development of diabetes in non-obese diabetic (NOD) mice. Clin Exp Immunol 1990; 81:400-405.
61. Reddy S, Bibby NJ, Elliott RB: Ontogeny of islet cell antibodies, insulin autoantibodies and insulitis in the non-obese diabetic mouse. Diabetologia 1988;31:322-328.
62. Serreze DV, Leiter EH, Kuff EL, Jardieu P, Ishizaka K: Molecular mimicry between insulin and retroviral antigen p73 Development of cross-reactive autoantibodies in sera of NOD and C57BL/ KsJ db/db mice. Diabetes 1988; 37:351-358.
63. Shimada A, Charlton B, Tayloredwards C, Fathman CG: Beta-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice. Diabetes 1996;45:1063-1067.
64. Lenschow DJ, Herold KC, Rhee L, Patel B, Koon A, Qin H-Y, Fuchs E, Singh B, Thompson CB, Bluestone JA: CD28/B7 Regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 1996; 5:285-293.
65. Chatenoud L, Thervet E, Primo J, Bach JF: Anti-CD3 antibody induces long-term remission of oven autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci USA 1994;91:123-127.
66. Maki T, Ichikawa T, Blanco R, Porter J: Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum. Proc Natl Acad Sci USA 1992;89: 3434-3438.
67. Pozzilli P, Signore A, Williams AJ, Reales PE: NOD mouse colonies around the world - recent facts and figures [review]. Immunol Today 1993;14:193-196.